byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
byUniversity of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainAs novel cancer treatments continually emerge, it is essential to collect data on patients' quality of life along wit
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
by Jim Stallard,Memorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainMantle cell lymphoma (MCL) is a rare and sometimes ruthless form of non-Hodgkin lymphoma. Even when treatme
by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
by SARA CLINE and LAURA UNGARBottles of abortion pills mifepristone, left, and misoprostol, right, are displayed at a clinic in Des Moines, Iowa, Sept. 22, 2010. Credit: AP Photo/Charlie Neibergall, F
by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
by NRG OncologyCredit: Pixabay/CC0 Public DomainThe NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The ph
Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo
by Johan Lundberg and Guusje Haver,The ConversationCredit: Unsplash/CC0 Public DomainPsilocybin, the psychedelic substance found in magic mushrooms, is a promising new treatment for psychiatric
by Johan Lundberg and Guusje Haver,The ConversationCredit: Unsplash/CC0 Public DomainPsilocybin, the psychedelic substance found in magic mushrooms, is a promising new treatment for psychiatric
by Lori SolomonThe U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pu
by Lori SolomonThe U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pu
by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente
by Lori SolomonThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presente
by Philip Crilly,The ConversationCredit: Pixabay/CC0 Public DomainBotulinum toxin, or Botox as it's widely known, is famous for its ability to smooth away wrinkles. But hiding our frown line
by Philip Crilly,The ConversationCredit: Pixabay/CC0 Public DomainBotulinum toxin, or Botox as it's widely known, is famous for its ability to smooth away wrinkles. But hiding our frown line
byPrinceton UniversityThis map shows the precise location and arrangement of the 50 largest neurons of the fly brain connectome. These 50, along with another 139,205 brain cells in the brain of
byPrinceton UniversityThis map shows the precise location and arrangement of the 50 largest neurons of the fly brain connectome. These 50, along with another 139,205 brain cells in the brain of
Some people of West African descent face a higher risk of renal failure. New drugs based on gene research may help right the ship — if they can reach everyone who needs them.
byKing's College LondonCredit: Unsplash/CC0 Public DomainAutomated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage kidney disea
byNIH/National Human Genome Research InstituteNIH researchers and collaborators have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of
Wearable brain imaging device shines a light on how babies respond in real-world situationsbyUniversity College LondonMother Mererid and baby Mabli were volunteers in the study. Credit: Liam Col
Breakthrough in Brain-Machine Interface: Chinese “Thought Communication” Becomes RealityCompared to decoding English’s 26 letters, decoding Chinese with its “418 syllables and 4 tones” presents a higher difficulty. ...At what age do people experience depression for the first time?Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...Health spending has been rising across rich countries with different systems...